105PDTG4010 IMMUNOTHERAPY COMBINED WITH FIRST-LINE CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC). PHASE 2B RESULTS OF THE TIME STUDY


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles